Document Detail


Acute myeloblastic leukemia in pregnancy: a case report and review of the literature.
MedLine Citation:
PMID:  15053082     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Leukemia is a rare event during pregnancy. The presence of leukemia during pregnancy raises several concerns about the effect of pregnancy on the prognosis of leukemia, the effect of the disease on pregnancy outcome and the teratogenic and mutagenic effect of chemotherapeutic agents on the fetus. We report a case of acute myeloblastic leukemia diagnosed during the third trimester of gestation and treated with chemotherapeutic agents before delivery. The duration of pregnancy was able to be prolonged for four weeks after clinical diagnosis of the disease and then terminated by cesarean section due to the presence of signs of fetal distress.
Authors:
M S Yucebilgin; S Cagirgan; A Donmez; E Ozkinay; F Akercan; L Mgoyi; F Vural
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  European journal of gynaecological oncology     Volume:  25     ISSN:  0392-2936     ISO Abbreviation:  Eur. J. Gynaecol. Oncol.     Publication Date:  2004  
Date Detail:
Created Date:  2004-03-31     Completed Date:  2004-06-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8100357     Medline TA:  Eur J Gynaecol Oncol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  126-8     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Ege University Facultè of Medicine, Izmir, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cytarabine / administration & dosage
Diagnosis, Differential
Drug Administration Schedule
Female
Humans
Idarubicin / administration & dosage
Leukemia, Myeloid, Acute / diagnosis*,  drug therapy
Pregnancy
Pregnancy Complications, Neoplastic / diagnosis*,  drug therapy
Pregnancy Trimester, Third
Chemical
Reg. No./Substance:
147-94-4/Cytarabine; 58957-92-9/Idarubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phyllodes tumor of the breast: case series of 40 patients.
Next Document:  Learning by ear: on the acquisition of case and gender marking by German-speaking children with norm...